Trim 25-30% of PG via scaled sells at $145-146; hard stop at $140, reassess at Q1 FY27 earnings
Trim 25-30% of PG exposure via scaled sells starting at current levels ($145-146) and adding additional size on any relief bounce to the 50/200 SMA cluster at $147-148. Hard stop on residual at $140 (below lower Bollinger at $142.55 and May structural low), not the trader's proposed $151 stop which is only 1.38 ATR away and will whipsaw on the 2.40 ATR. Maintain dividend capture on 70-75% residual through late-October ex-date. The convergence across all three analysts on directional Underweight is decisive; the conservative analyst's full Hold overweights the quality floor and underweights the bounded-alpha history. The bounded-alpha ceiling (30.3% ROE, 0.38 beta, 67-year dividend streak, A+ credit, $15.1B FCF) prevents a full Sell rating. UPGRADE to Hold on close above $148.71 on volume >6M with MACD bullish cross OR Q1 FY27 organic >2% with gross margin >50% AND EPS >$1.40. UPGRADE to Overweight on close above $152 with margin stabilization AND FY27 EPS guidance >$7.20. DOWNGRADE to Sell on close below $140 on expanding volume OR FY27 headwind guidance >$1.8B OR dividend cut signal OR Q1 FY27 organic <1% with gross margin <48% AND EPS <$1.30.
| Position | Action |
|---|---|
| Current levels ($145-146) | Initiate trim 25-30% of PG exposure via scaled sells |
| Test of 50/200 SMA cluster at $147-148 | Add additional trim size on relief bounce to the MA cluster |
| Residual 70-75% position held | Maintain dividend capture through late-October ex-date |
PG's "boring" defensive profile masks an asymmetric risk/reward setup where the macro headwinds and $1.4B FY27 earnings headwind are already fully priced in, creating a coiled spring technical pattern that could resolve sharply higher once the innovation pivot and growth acceleration prove credible.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 146.21 | bearish |
| 50 SMA | 145.92 | neutral |
| 200 SMA | 145.92 | bullish |
| RSI (14) | 49.46 | neutral |
| MACD Line | 0.286 | bullish |
| MACD Signal | 0.16 | bullish |
| MACD Histogram | +0.13 | bearish |
| Bollinger Middle (20 SMA) | 145.68 | neutral |
| Bollinger Upper | 148.72 | bearish |
| Bollinger Lower | 142.64 | bullish |
| ATR (14) | 2.40 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Test of 50/200 SMA cluster at $147-148
Then: Add trim size on bounce to cluster
Macro headwinds are already fully priced in — the stock has underperformed dramatically relative to the S&P 500
↩ rebuts: “Macro headwinds will continue to pressure the stock”
EV: ~16% total return · concedes: All stated macro headwinds (10Y at 2007 highs, 92% Fed hike odds, oil over $100) are accurate and real; $1.4B earnings headwind will materialize in FY27; Stock is currently flat-to-down and below 52-week high of $167.25; PG has underperformed S&P 500 by 15.4% over 6 months; The technical reversal day at $145.68 did occur
PG's "coiled spring" technical setup is actually a bearish alignment with deteriorating momentum, macro headwinds (10Y at 2007 highs, 92% hike odds), unproven innovation pivots, real-time Haleon shelf-share competition, and symmetric but unfavorable risk/reward—making SELL the appropriate rating.
EV: -$4% (7% downside plus 3% dividend yield vs S&P 500) · concedes: Innovation launches materially exceed expectations; Fed pivots dovish unexpectedly; PG acquires a competitor to consolidate shelf-share war; Would consider downgrading to HOLD on any of those, but won't be buyer until $145 floor holds with conviction or headline macro regime changes
→ vs conservative: The Dividend Aristocrat narrative (66 years of hikes, 2.95% yield) is invalidated by Treasuries at 2007 highs—the yield premium that underpinned the defensive thesis is gone; 22x P/E for near-risk-free yield is not a quality floor but a trap
→ vs conservative: The 30.3% ROE is a mirage—$143B in treasury stock has shrunk the equity denominator, and declining operating income ($20.45B to $19.75B) reveals deteriorating unit economics underneath
→ vs conservative: Low beta (0.38) protects against volatility but not multiple compression; in 2022 rising-rate environment, low-beta staples were crushed alongside everything else
→ vs neutral: The 50/200 SMA kiss at $145.92 is a coiled spring, not neutral—compression patterns resolve in the direction fundamentals are pointing, not randomly; waiting for 'confirmation' means catching a falling knife from $140
→ vs neutral: The innovation pipeline (Head & Shoulders HydraZinc, Oral-B iO) takes 18-36 months while the $1.4B FY27 headwind arrives sooner; CFO's willingness to trade margin for growth is a confession, not a catalyst
→ vs neutral: 'Underperformance already priced' is lazy—the PEG of 3.77 and 22x earnings in a structurally rising rate environment mean multiple compression has barely started
| neutral |
| VWMA | 145.75 | bearish |
Support: 142.64 · 142.34 | Resistance: 148.72 · 149.18
PG is in a directionless, mean-reverting regime after a sharp mid-summer selloff from $153.18 (2026-07-17) to $142-$143 zone. Price closed at $145.68 on 2026-09-24 with a bearish intraday reversal (-1.16%), sitting at the 50/200 SMA confluence of $145.92. All moving averages are clustered at 145.92-146.21, indicating equilibrium with a neutral-to-slightly-bearish near-term skew. RSI printed 49.46 with a lower-high pattern (41.5 on 9/9 → 56.7 on 9/17 → 49.5 on 9/24), confirming waning upside momentum. MACD remains bullish (line 0.286 above signal 0.16) but histogram has narrowed from $0.36 to +$0.13, indicating rapid momentum deceleration. Bollinger Bandwidth has compressed significantly (upper-lower spread ~$6 vs ~$10 earlier), with price closing exactly at the middle band ($145.68). ATR has collapsed 34% from $3.62 to $2.40, supporting the range-trading thesis. VWMA at $145.75 is below today's close ($145.68), showing lack of institutional conviction. Composite verdict: Neutral / Range-Bound with mild bearish near-term skew. Recommendation: HOLD existing positions; WAIT for breakout above $148.72 or breakdown below $142.64 before new entries.
Market Cap
$338.4B
P/E (TTM)
22.0x
Forward P/E
19.7x
PEG Ratio
3.77
P/B
6.35x
EV/EBITDA
~13.8x
Dividend Yield
2.95%
Beta
0.377
Gross Margin
~50.9%
Operating Margin
22.1%
Net Margin
18.4%
ROE
30.3%
ROA
10.7%
Gross Profit (TTM)
$44.28B
EBITDA (TTM)
$24.75B
Net Income (TTM)
$15.75B
Revenue (FY2026)
$87.0B
Diluted EPS (FY2026)
$6.62
Revenue Growth (FY2026)
+3.3% YoY
EPS Growth (FY2026)
+1.7% YoY
FCF Growth (FY2026)
+7.8% YoY
Free Cash Flow (TTM)
$15.15B
Operating Cash Flow (TTM)
$19.56B
OCF/Net Income
1.22x
Net Debt
$24.2B
Total Debt
$35.03B
D/E
~64.5%
Current Ratio
0.68
Total Assets
$126.52B
Book Value/Share
$22.95
Goodwill + Intangibles
$62.7B
Dividends Paid (FY2026)
$10.23B
Share Repurchases (FY2026)
$5.03B
Total Capital Returns (FY2026)
$15.26B
Dividend Growth (4-yr CAGR)
~4.4%
52-Week High
$167.25
52-Week Low
$137.62
50-Day MA
$146.12
200-Day MA
$147.48
Forward EPS
$7.40
Interest Expense
$877M
Effective Tax Rate
20.8%
CapEx (FY2026)
$4.41B
Inventory
$8.17B
Cash & Equivalents
$9.94B
Treasury Stock
$143B
Strengths
Concerns
PG is a best-in-class consumer defensive franchise generating $15.75B in net income and $15.15B in free cash flow with exceptional 30.3% ROE and 50.9% gross margins. The company has delivered accelerating revenue growth (+3.3% in FY2026) while maintaining its Dividend Aristocrat status with 66+ years of consecutive dividend increases and returning ~95% of FCF to shareholders. However, the stock trades at a rich 22x P/E and 3.77x PEG ratio that prices in its quality premium with limited upside, making it best suited as a core defensive holding rather than an aggressive growth play. Rating: HOLD.
Macro: Hawkish regime shift underway: 10-year Treasury yield at highest level since 2007, 30-year at multi-decade highs. Polymarket prices 92% probability of at least one more Fed rate hike in 2026, with 97% probability of no cuts in 2026. Jamie Dimon stated inflation is not clearly defeated. Oil above $100 adds geopolitical risk premium. US recession odds remain low at 10% — consensus is stagflation-lite, not recession. Higher long-end yields compress present value of PG's future cash flows, flipping the 'rate-cut beneficiary' narrative to a headwind.